Why is KeepSight effective?
An excerpt from Optometry Australia's Optometry Connection Magazine - July issue. Written by Dr Joseph Paul, Head of Professional Services at Specsavers Australia New...
Kiwis with diabetes unaware of their risk of eye disease
A survey of 123 members of the Diabetes New Zealand community has revealed a shocking lack of knowledge around diabetic retinopathy, despite many members...
New partnership puts focus on nAMD treatment adherence rates
Specsavers and Macular Disease Foundation Australia are announcing a strategic scoping partnership with a vision to increase and enhance support for patients diagnosed with...
Glaucoma detection and referral in Australia’s most locked down states
The past 18 months have been anything but ordinary. COVID-19 restrictions and prolonged lockdowns across states and regions have impacted access to eyecare across...
The impact of the past 12 months on patient care – an analysis of...
The past 12 months have been anything but ordinary. COVID-19 restrictions have impacted access to eye care across Australia, with prolonged lockdowns restricting optometrists from...
CASE STUDY: Doug Perkins Medal recipient’s glaucoma success
Data is a driving force behind many aspects of excellence in patient care. It enables an understanding of the incremental clinical activities that optometrists...
Are there enough optometrists in Australia?
In 2018, a report by Deloitte Access Economics was commissioned by Specsavers which investigated the supply and demand of Australia’s optometric workforce until 2037.
The...
The rates of optometric attendance and referral for patients with diabetes
In December 2018, ahead of the launch of KeepSight in April 2019, Specsavers invested in the enhancement of its patient management system, enabling a consistent...
Using visual field assessment to detect glaucoma
OCT helps to facilitate the detection of glaucoma at a stage where visual field loss is minimal, allowing the greatest opportunity for patients to...